Yüklüyor......
Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1
Breast cancer cells have different requirements on metabolic pathways in order to sustain their growth. Triple negative breast cancer (TNBC), an aggressive breast cancer subtype relies mainly on glycolysis, while estrogen receptor positive (ER+) breast cancer cells possess higher mitochondrial oxida...
Kaydedildi:
| Yayımlandı: | Front Cell Dev Biol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6141706/ https://ncbi.nlm.nih.gov/pubmed/30255019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2018.00113 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|